Biocon

At the influential CPHI China 2025 in Shanghai, leading Indian biopharmaceutical company Biocon showcased its global capabilities from a 60 sqm stand. The exhibit served as a strategic nexus for the key Asia-Pacific market, reinforcing the company’s commitment to scientific innovation and partnership. It was a clear statement of Biocon’s mission to develop and supply high-quality, complex biosimilars and active pharmaceutical ingredients to a worldwide network.

The booth was designed with a focus on fostering B2B collaboration and supply chain development. The clean, professional layout featured semi-private meeting areas for confidential discussions and clear graphics detailing Biocon’s extensive product portfolio and technological platforms. The primary objective was to connect with new licensing and distribution partners while strengthening existing relationships, solidifying Biocon’s reputation as a reliable, large-scale manufacturing partner.